Aluda Pharmaceuticals approaches drug discovery with a deep understanding of biology. Our domain is the signaling between and within cells that is central to immunological defense, inflammation and pathogenesis across many disease states.
We have a team with extensive experience in drug discovery and development through clinical phase II and bring specific knowledge of molecular design to our drugs.
Our programs include both new and previously explored drug targets, and we deploy best practices in discovery, from target validation and optimization to selection of leads and clinical strategies with highest ROI in the partnering marketplace.
Specific focus areas include:
- Extracellular vesicles as mediators for cell-cell communication, including their formation, transportation and release, and molecular mechanisms involved in these biological processes
- Signal transduction pathways in which counter-acting cell types can be identified to have roles in disease pathology
- Rational design of new chemical entities based on the scientific evidence and practical experience with medicinal chemistry within our specific area
- New points of intervention in the mechanistic components of cancer, inflammation, and viral infections
This document was printed from http://www.aludapharm.com/index.html